Results 191 to 200 of about 157,469 (244)

Eosinophilic annular erythema in a patient with hepatitis B-related cirrhosis. [PDF]

An Bras Dermatol
Vilela BF, Fialho MC, Ferreirinha A, Fernandes C.   +3 more
europepmc   +1 more source

Emerging Deep Cutaneous Fungal Infection Caused by Cyphellophora Species in a Diabetic Patient

The Kaohsiung Journal of Medical Sciences, EarlyView.
Yi‐Shan Teng, Pei‐Lun Sun, Cheng‐Che E. Lan   +2 more
wiley   +1 more source

An Open‐Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington's Disease

Movement Disorders, EarlyView.
Complement activation is implicated in Huntington's disease; ANX005 is a potent inhibitor of component C1q. ANX005 exhibited a generally manageable safety profile with rapid reduction in C1q in the cerebrospinal fluid. Functional ability on composite Unified Huntington's Disease Rating Scale and total functional capacity was maintained, with potential ...
Rajeev Kumar, Pinky Agarwal, Karen Anderson, Daniel Claassen, Marissa Dean, Andrew Duker, Burton Scott, Benjamin Hoehn, Ann Mongan, Ping Lin, Ellen Cahir‐McFarland, Lori Taylor, Glenn Morrison, Ted Yednock, Sanjay Keswani, Henk‐Andre Kroon   +15 more
wiley   +1 more source

LetibotulinumtoxinA for Rosacea: A Pilot Study. [PDF]

Toxins (Basel)
Bańka-Wrona A, Wrona W, Barańska-Rybak W.   +2 more
europepmc   +1 more source

Dermoscopy in Necrolytic Acral Erythema: A Case Report

Dermatology Practical & Conceptual
Shivani Bansal, Parul Chojer, Sushama Sushama, Manjit Kaur Rana   +3 more
doaj   +1 more source

An Occult Odontogenic Infection Behind a Persistent Left Chin Nodule

The Kaohsiung Journal of Medical Sciences, EarlyView.
Yi‐Shan Teng, Huei‐Jing Wang, Shih‐Tsung Cheng   +2 more
wiley   +1 more source

Real‐World Safety and Effectiveness of Glatiramer Acetate in Patients With Multiple Sclerosis: Final Results of Post‐Marketing Surveillance in Japan

Neurology and Clinical Neuroscience, EarlyView.
ABSTRACT Background Glatiramer acetate is an injectable disease‐modifying therapy indicated for multiple sclerosis (MS). Aim To evaluate the real‐world safety and effectiveness of glatiramer acetate for MS in Japan. Methods A prospective, multicenter, observational, all‐case post‐marketing survey was conducted in Japan between November 2015 and March ...
Masaaki Niino, Eriko Hayashi, Mai Itani, Jun‐ichi Kira   +3 more
wiley   +1 more source

Bullous Pemphigoid Following IgG/IgA Pemphigus: Possible Involvement of SGLT2 and DPP-4 Inhibitors. [PDF]

Acta Derm Venereol
Ikeda A, Tani N, Ishii N, Koga H, Yoshida Y.   +4 more
europepmc   +1 more source